| 发明名称 |
SALT FORMS OF ORGANIC COMPOUND |
| 摘要 |
The present invention relates to novel salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine, a DPP-4 inhibitor and their use in pharmaceutical compositions useful in the treatment of type 2, diabetes, as well as their production.
|
| 申请公布号 |
US2012129874(A1) |
申请公布日期 |
2012.05.24 |
| 申请号 |
US200913140853 |
申请日期 |
2009.12.22 |
| 申请人 |
SIEGER PETER;PFRENGLE WALDEMAR;BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
SIEGER PETER;PFRENGLE WALDEMAR |
| 分类号 |
A61K31/522;A61P3/10;C07D473/04 |
主分类号 |
A61K31/522 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
